Neonatal Drug Therapy: The First Frontier of Therapeutics for Children

K Allegaert; John van den Anker

doi:10.1002/cpt.166

Neonatal Drug Therapy: The First Frontier of Therapeutics for Children

K Allegaert, John van den Anker

Pediatric Surgery

Research output: Contribution to journal › Article › Academic › peer-review

68 Citations (Scopus)

Abstract

Knowledge about the safe and effective use of medicines in neonates has increased substantially but has resulted in few label changes. Drugs developed for use in adults are reshaped and tailored to specific neonatal indications. However, the use of drugs in neonates should not only mirror adult pharmacotherapy, but should be driven by their own specific needs. Therefore, building collaborative networks may assist to develop a newborn-driven research agenda addressing their clinical needs and diseases.

Original language	Undefined/Unknown
Pages (from-to)	288-297
Number of pages	10
Journal	Clinical Pharmacology & Therapeutics
Volume	98
Issue number	3
DOIs	https://doi.org/10.1002/cpt.166
Publication status	Published - 2015

Access to Document

10.1002/cpt.166

Cite this

@article{1da5a48893e04da3b51b2f3bba256385,

title = "Neonatal Drug Therapy: The First Frontier of Therapeutics for Children",

abstract = "Knowledge about the safe and effective use of medicines in neonates has increased substantially but has resulted in few label changes. Drugs developed for use in adults are reshaped and tailored to specific neonatal indications. However, the use of drugs in neonates should not only mirror adult pharmacotherapy, but should be driven by their own specific needs. Therefore, building collaborative networks may assist to develop a newborn-driven research agenda addressing their clinical needs and diseases.",

author = "K Allegaert and {van den Anker}, John",

year = "2015",

doi = "10.1002/cpt.166",

language = "Undefined/Unknown",

volume = "98",

pages = "288--297",

journal = "Clinical Pharmacology & Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Neonatal Drug Therapy: The First Frontier of Therapeutics for Children

AU - Allegaert, K

AU - van den Anker, John

PY - 2015

Y1 - 2015

N2 - Knowledge about the safe and effective use of medicines in neonates has increased substantially but has resulted in few label changes. Drugs developed for use in adults are reshaped and tailored to specific neonatal indications. However, the use of drugs in neonates should not only mirror adult pharmacotherapy, but should be driven by their own specific needs. Therefore, building collaborative networks may assist to develop a newborn-driven research agenda addressing their clinical needs and diseases.

AB - Knowledge about the safe and effective use of medicines in neonates has increased substantially but has resulted in few label changes. Drugs developed for use in adults are reshaped and tailored to specific neonatal indications. However, the use of drugs in neonates should not only mirror adult pharmacotherapy, but should be driven by their own specific needs. Therefore, building collaborative networks may assist to develop a newborn-driven research agenda addressing their clinical needs and diseases.

U2 - 10.1002/cpt.166

DO - 10.1002/cpt.166

M3 - Article

SN - 0009-9236

VL - 98

SP - 288

EP - 297

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

IS - 3

ER -